Corrigendum: Application of the distally based sural neurocutaneous flaps in the management of foot and ankle defects in patients with diabetic foot (Front. Endocrinol., (2022), 13, 1009714, 10.3389/fendo.2022.1009714)

1Citations
Citations of this article
3Readers
Mendeley users who have this article in their library.

Abstract

In the published article, there was an error in Figure 1 as published. As the authors were careless in picture editing, they have amended the figure to provide improved clarity. The corrected Figure 1 and its caption "Case 1: Te distally based sural neurocutaneous flaps for reconstruction of the heel soft tissue defect. (A) Diabetic wound at the heel. (B) Harvest of the distally based sural neurocutaneous flap. (C) The defect was reconstructed with a flap, and the donor site was covered with skin graft. (D) The flap and the donor site were completely healed at follow-up" appear below. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Cite

CITATION STYLE

APA

Dai, J., Zhou, Y., Mei, S., & Chen, H. (2022, November 23). Corrigendum: Application of the distally based sural neurocutaneous flaps in the management of foot and ankle defects in patients with diabetic foot (Front. Endocrinol., (2022), 13, 1009714, 10.3389/fendo.2022.1009714). Frontiers in Endocrinology. Frontiers Media S.A. https://doi.org/10.3389/fendo.2022.1054322

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free